Plain-English translation of NCT06588270 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new virtual reality therapy designed to help people with schizophrenia who experience negative symptoms—like reduced motivation, emotional flatness, or difficulty speaking. Participants will use virtual reality equipment with interactive activities and games, guided by a therapist, once a week for 12 weeks. The study will compare this active treatment to a control group that uses the same virtual reality equipment but without the therapeutic activities.
Negative symptoms of schizophrenia—such as withdrawn behavior, lack of motivation, and difficulty expressing emotions—are hard to treat with current medications and therapy. This trial explores whether immersive, goal-directed virtual reality experiences could offer a new way to help people manage these symptoms.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will attend 12 weekly therapy sessions, each lasting about 20 minutes, where you'll use virtual reality equipment with a therapist present. Half of participants will use VR software designed to help treat negative symptoms through interactive activities and rewards; the other half will use neutral VR environments. You'll continue taking your regular schizophrenia medications and receiving your usual care throughout the study.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Chile